STERIS’s fourth quarter results received a negative reaction from the market despite surpassing Wall Street’s revenue expectations and reporting adjusted earnings per share in line with consensus.

Daniel Carestio, President and CEO, highlighted an increased outlook for fiscal 2026 due to strong first-half performance, noting, "We now anticipate approximately 8% to 9% as reported revenue growth, ...

In the news: Carestio became president and CEO of medical equipment company Steris in 2021, after previously serving as its COO. He had been with the company for more than 20 years in a variety of ...

Daniel A Carestio's most active month to dispose stocks was the month of September. 2020 saw Daniel A Carestio paying a total of $2,630,085.00 for 104,208 shares, this is the most they've acquired in ...

Good day, and welcome to the STERIS plc First Quarter 2026 Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Julie ...

In the news: The medical equipment and life sciences company in April said it had agreed to sell its dental segment to Peak Rock Capital, a middle-market private investment firm, for $787.5 million in ...

Daniel A Carestio's most active month to dispose stocks was the month of September. 2020 saw Daniel A Carestio paying a total of $2,630,085.00 for 104,208 shares, this is the most they've acquired in ...